# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-15T16:14:04.225701
**Route:** Direct Google API + PDF
**Tokens:** 20997 in / 2228 out
**Response SHA256:** 85fc01b10d510e7a

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: HCBS Provider Panel"
**Page:** 9
- **Formatting:** Clean, standard three-line table. However, the alignment of numbers is inconsistent; decimal points are not aligned (e.g., compare "874" to "119.16").
- **Clarity:** Good. It clearly shows the growth in provider counts and billing between periods.
- **Storytelling:** Strong. It sets the stage for the "null result" by showing that the raw means actually increased during the unwinding.
- **Labeling:** Clear. The sub-headings (Pre/Post) are helpful.
- **Recommendation:** **REVISE**
  - Decimal-align all numeric columns.
  - Add a note explaining what "Net Entry" represents (absolute count vs. rate).
  - Clarify the unit for "Individual Providers (share)"—is it 0.064% or a fraction?

### Table 2: "Medicaid Unwinding Treatment Cohorts"
**Page:** 10
- **Formatting:** Professional and sparse. 
- **Clarity:** Excellent. Provides the necessary context for the staggered DiD identification.
- **Storytelling:** Essential. It demonstrates the variation in treatment timing and intensity.
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS**

### Table 3: "Main Results: Effect of Medicaid Unwinding on HCBS Providers"
**Page:** 13
- **Formatting:** Typical AER/QJE style. Decimal alignment is better here than in Table 1. 
- **Clarity:** High. The four outcomes cover the logical bases of "supply."
- **Storytelling:** The "money table" of the paper. It establishes the null.
- **Labeling:** Standard errors are in parentheses, stars are defined.
- **Recommendation:** **REVISE**
  - Add a "Mean of Dep. Var." row at the bottom to help readers interpret the magnitude of the coefficients.
  - Explicitly state in the notes that all specifications include state and month fixed effects.

### Figure 1: "National HCBS Provider Counts Over Time"
**Page:** 14
- **Formatting:** Modern ggplot2 style. The vertical dashed line is helpful.
- **Clarity:** The drop-off at the end of 2024 (visible in the blue line) is jarring and likely due to data reporting lags/right-censoring.
- **Storytelling:** Good for showing the secular trend, but the sharp drop at the very end might distract a reviewer into thinking providers *did* collapse.
- **Labeling:** "A. Active HCBS Providers by Month" is redundant with the figure title.
- **Recommendation:** **REVISE**
  - Truncate the x-axis or add a note if the 2024 drop is due to "claims run-out" (reporting lags).
  - Remove the "A." internal label to clean up the white space.

### Figure 2: "Event Study: Effect of Unwinding on Log HCBS Providers"
**Page:** 15
- **Formatting:** Professional. Shaded 95% CIs are standard.
- **Clarity:** Very clear, though the secular trend (slope) is visually dominant.
- **Storytelling:** Risky. In a top journal, this "pre-trend" will be attacked. While the author explains it as a secular trend, a detrended version might be more persuasive.
- **Labeling:** Excellent.
- **Recommendation:** **REVISE**
  - Consider adding a second panel or a second line showing the event study coefficients after removing a linear state-specific time trend.

### Figure 3: "Callaway-Sant’Anna Dynamic ATT: Log HCBS Providers"
**Page:** 17
- **Formatting:** Clean. Use of different colors for Pre/Post is helpful.
- **Clarity:** Good. It contrasts well with Figure 2 by showing a "flat" null.
- **Storytelling:** Crucial for addressing the "Bad TWFE" critique in modern DiD.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Table 4: "Treatment Intensity and Heterogeneity"
**Page:** 18
- **Formatting:** **CRITICAL ERROR.** The variable names are unformatted (e.g., `disenrollrateÖpost`). This looks like raw software output.
- **Clarity:** Poor due to the "leakage" of code into the table.
- **Storytelling:** Important for showing the "dose-response" (or lack thereof).
- **Labeling:** Incomplete. Needs "clean" labels for interaction terms.
- **Recommendation:** **REVISE**
  - Rename `disenrollrateÖpost` to "Disenrollment Rate $\times$ Post".
  - Rename `proceduralshareÖpost` to "Procedural Share $\times$ Post".
  - Ensure columns 3-5 have the dependent variable clearly labeled in the header or sub-header.

### Figure 4: "Treatment Intensity: Disenrollment Rate vs. Provider Change"
**Page:** 19
- **Formatting:** Good use of state abbreviations as labels.
- **Clarity:** Very high. One of the best figures in the paper for "10-second parsing."
- **Storytelling:** Strong evidence for the null.
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS**

### Figure 5: "Heterogeneity: Individual vs. Organizational HCBS Providers"
**Page:** 20
- **Formatting:** Consistent with Figure 1.
- **Clarity:** The indexing to 100 makes the comparison easy.
- **Storytelling:** Supports the heterogeneity null.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Table 5: "Market Concentration Effects"
**Page:** 21
- **Formatting:** Clean.
- **Clarity:** Good.
- **Storytelling:** Secondary but important for the "Industrial Organization" contribution mentioned in the intro.
- **Labeling:** Clear.
- **Recommendation:** **MOVE TO APPENDIX** (This result is a "null on a null" and less central than the main provider counts).

### Figure 6: "HCBS Market Concentration Over Time"
**Page:** 22
- **Formatting:** Consistent with others.
- **Clarity:** The HHI scale (300-500) shows very low concentration; this should be highlighted.
- **Storytelling:** Weak. The line is almost flat.
- **Labeling:** Good.
- **Recommendation:** **MOVE TO APPENDIX**

### Figure 7: "Placebo: HCBS vs. Non-HCBS Providers"
**Page:** 23
- **Formatting:** Clean.
- **Clarity:** High.
- **Storytelling:** Very strong. It validates the research design.
- **Labeling:** The legend is descriptive.
- **Recommendation:** **PROMOTE TO MAIN TEXT** (Move closer to the main results, possibly combining with Figure 1 as Panel B).

### Table 6: "Robustness Checks"
**Page:** 24
- **Formatting:** Good.
- **Clarity:** Concise summary of multiple models.
- **Storytelling:** Standard for top-tier papers.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

## Appendix Exhibits

### Figure 8: "Permutation Inference: 1,000 Random Reassignments"
**Page:** 25
- **Formatting:** Clean histogram.
- **Clarity:** Excellent. The red line vs. distribution is very intuitive.
- **Storytelling:** Essential robustness for a null result.
- **Recommendation:** **KEEP AS-IS**

### Figure 9: "Leave-One-Out Stability"
**Page:** 26
- **Formatting:** "Dot plot" style is appropriate.
- **Clarity:** Very clear.
- **Storytelling:** Proves no single state (like CA or TX) is driving the result.
- **Recommendation:** **KEEP AS-IS**

### Figure 10: "Medicaid Unwinding Start Date by State"
**Page:** 37
- **Formatting:** Map is a bit small.
- **Clarity:** Good for visualizing geographic variation.
- **Storytelling:** Helpful context but correctly placed in the appendix.
- **Recommendation:** **KEEP AS-IS**

---

## Overall Assessment

- **Exhibit count:** 5 main tables, 7 main figures, 1 appendix table, 3 appendix figures.
- **General quality:** High. Most figures use a consistent aesthetic, and the tables (with the exception of Table 4) are professional.
- **Strongest exhibits:** Figure 4 (Dose-Response scatter) and Figure 8 (Permutation test).
- **Weakest exhibits:** Table 4 (contains raw code variable names) and Figure 1 (unexplained data drop-off at the end of the series).
- **Missing exhibits:** A **Map of Treatment Intensity** (disenrollment rates by state) would be a great companion to Figure 10 to show where the "shocks" were largest.

### Top 3 Improvements:
1. **Fix Table 4 formatting:** Replace `Ö` and code-style variable names with LaTeX/formatted text immediately. This is a "desk reject" level error in some journals.
2. **Address the Figure 1/7 data drop:** If the sharp decline in late 2024 is due to incomplete claims reporting (run-out), the figures should be truncated at a reliable month (e.g., June 2024) to avoid giving the false impression of a late-period collapse.
3. **Consolidate/Streamline Main Text:** Move the Market Concentration (Table 5/Figure 6) to the Appendix and bring the Placebo Figure (Figure 7) forward. The placebo is a much stronger "sell" for the validity of your null than the HHI results.